December 27, 2016
Seattle Genetics’ cancer drug put on clinical hold after four deaths
Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies.